An Optimized Method to Produce Human-Induced Pluripotent Stem Cell-Derived Limbal Stem Cells Easily Adaptable for...

Area of Science:

• Ophthalmology
• Stem Cell Biology
• Regenerative Medicine

Background:

• Limbal stem cells (LSC) maintain corneal transparency, and their deficiency (LSCD) causes blindness.
• Current LSCD treatments aim to restore corneal function by replacing damaged LSC.
• Induced pluripotent stem cells (iPSC) offer a promising alternative cell source for LSCD therapy.

Purpose of the Study:

• To develop an efficient and scalable method for producing LSC-like cells from iPSC.
• To evaluate the suitability of these iPSC-derived LSC for transplantation.
• To establish a preclinical model for LSCD treatment.

Main Methods:

• A synthetic mRNA protocol was used to reprogram bone marrow mesenchymal stem cells into iPSC.
• iPSC were differentiated into LSC-like cells within 12 days.
• Cells were seeded onto amniotic membrane or fibrin gel scaffolds for transplantation.

Main Results:

• The protocol yielded high-purity LSC-like cells rapidly and reproducibly.
• The iPSC-LSC could be successfully cultured on both amniotic membrane and fibrin gel scaffolds.
• In vivo studies confirmed the feasibility of transplanting an iPSC-LSC fibrin patch.

Conclusions:

• An efficient, standardized method for generating patient-specific LSC from iPSC has been established.
• The iPSC-LSC, when seeded on a fibrin gel scaffold, are suitable for transplantation.
• This approach holds significant potential for treating LSC-deficiency diseases and restoring corneal transparency.